Arthur C. Butcher - Mar 12, 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: Director
Signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Arthur Butcher
Stock symbol: STAA
Transactions as of: Mar 12, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/14/2024, 05:13 PM
Previous filing: Feb 27, 2024
Next filing: May 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Award	$0	+649		$0.00	649	Mar 12, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Common Stock Options	Award	$0	+1.16K		$0.00	1.16K	Mar 12, 2024	Common stock	1.16K	$37.64	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective March 12, 2024, the Board of Directors appointed Mr. Butcher to serve as a member of the Board and granted him, as a non-employee director, 649 restricted shares and options to purchase 1,163 shares of common stock, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares and stock options vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.

Content

Effective March 12, 2024, the Board of Directors appointed Mr. Butcher to serve as a member of the Board and granted him, as a non-employee director, 649 restricted shares and options to purchase 1,163 shares of common stock, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares and stock options vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.